Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrent High Grade Meningioma × Trabectedin × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 7 Solitary Fibrous Tumors 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Recurrent High Grade Meningioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leiomyosarcoma Uterus 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234050 2025-07-10

Trabectedin for Recurrent Grade II/III Meningioma

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed

90 enrolled 18 charts

Recurrent High Grade Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡